TP53 and cancer: Statins were found to reduce protein levels of conformational p53 mutants (R156P, Y157F, R175H, and Y220C) in human and murine cancer cell lines by liberating mutp53 from its protective interaction with DNAJA1 and enabling CHIP-mediated degradation.